XOMA Provides Update on Gevokizumab – Analyst Blog
Posted on January 02, 2013 at 14:45 PM EST
XOMA intends to include active non-infectious anterior scleritis in the gevokizumab proof-of-concept program
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here